Stay updated with breaking news from Associate Professor Head. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--BrainChip Holdings Ltd (ASX: BRN, OTCQX: BRCHF, ADR: BCHPY), the world’s first commercial producer of ultra-low power, fully digital, event-based, neuromorphic
Mike Hajimichael, famously known as Haji Mike, will be in London next month to perform an exclusive gig at My Time in Palmers Green (375 Green Lanes, London N13 4JG). A professor at the University of Nicosia, as well as DJ, performer, poet, song writer and author, Haji Mike will be giving an acoustic performance
Taysha Gene Therapies Announces Initiation of Clinical Development of TSHA-118 for the Treatment of CLN1 Disease
Hits: 889 TSHA-101 to be first bicistronic vector evaluated in human clinical trials; TSHA-101 designed to deliver both HEXA and HEXB transgenes within a single AAV9 vector construct TSHA-101 CTA is the second clinical trial clearance received, in addition to TSHA-118’s open investigational new drug application for CLN1 Interim data from Phase 1/2 trial anticipated in 2021 DALLAS, TX, USA I December 21, 2020 I Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogeni...